Insmed (INSM) Research & Development (2010 - 2026)

Insmed's Research & Development history runs 17 years deep, the most recent figure standing at $209.5 million for Q1 2026.

• In Q1 2026, Research & Development rose 37.3% year-over-year to $209.5 million; the TTM figure through Mar 2026 stood at $828.0 million (up 31.46% YoY), while the FY2025 annual figure was $771.1 million, up 28.87% from the prior year.
• Research & Development for Q1 2026 stood at $209.5 million, down from $254.9 million in the prior quarter.
• The five-year high for Research & Development was $254.9 million in Q4 2025, with the low at $84.4 million in Q1 2022.
• The 5-year median for Research & Development is $146.7 million (2024), against an average of $149.9 million.
• The sharpest annual moves came in 2023 and 2024: Research & Development jumped 122.5% in 2023, then decreased 25.5% in 2024.
• Insmed's Research & Development stood at $124.8 million in 2022, then grew by 9.83% to $137.0 million in 2023, then surged by 31.16% to $179.7 million in 2024, then jumped by 41.83% to $254.9 million in 2025, then declined by 17.82% to $209.5 million in 2026.
• Business Quant data shows INSM's Research & Development at $209.5 million in Q1 2026, $254.9 million in Q4 2025, and $186.4 million in Q3 2025.